COVID-19疫苗接种后腋窝淋巴结DOTATATE摄取
一例58岁男性肺神经内分泌肿瘤术后辅助化疗后随访,行DOTATATE PET/CT,接种强生COVID-19疫苗1天后右三角肌注射,见DOTATATE PET-avid腋窝淋巴结。已知所有3种FDA批准COVID-19疫苗可致区域淋巴结反应性改变,近期数据显示接种后FDG PET-avid腋窝淋巴结病,本报告为强生疫苗接种后DOTATATE PET-avid腋窝淋巴结。
要点
- COVID-19疫苗接种后可出现区域腋窝淋巴结反应性改变。
- DOTATATE PET/CT也可显示疫苗后腋窝淋巴结摄取。
- 判读DOTATATE PET/CT时需结合近期疫苗接种史。
核心结论
- COVID-19疫苗接种后腋窝淋巴结可出现DOTATATE PET摄取,需与肿瘤转移鉴别。
研究设计与样本
- 个案报告:58岁男性肺神经内分泌肿瘤术后辅助化疗后随访行DOTATATE PET/CT。
主要发现
- 接种强生COVID-19疫苗1天后右三角肌注射,DOTATATE PET/CT见腋窝淋巴结摄取。
- 所有3种FDA批准COVID-19疫苗均可致区域淋巴结反应性改变。
- 近期发表数据显示COVID-19疫苗接种后FDG PET-avid腋窝淋巴结病。
临床怎么用
- 核医学科医生判读DOTATATE PET/CT时应询问近期COVID-19疫苗接种史。
- 对疫苗同侧腋窝淋巴结摄取应结合接种史考虑反应性改变。
局限性
- 个案报告,不能确定发生率或推广至所有患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 58-year-old man underwent DOTATATE PET/CT scan for follow-up of pulmonary neuroendocrine tumor after resection and adjuvant chemotherapy. On screening paperwork, the patient indicated having received the Johnson & Johnson/Janssen COVID-19 vaccine (Janssen Biotech, Inc) 1 day previously, administered in the right deltoid muscle. Reactive changes in regional lymph nodes is a known response for all 3 currently Food and Drug Administration-approved COVID-19 vaccines. Recent published data have demonstrated FDG PET-avid axillary lymphadenopathy subsequent to COVID-19 vaccination, and included here is a report of DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson COVID-19 vaccine.
引用
- Brophy J, Henkle G, Rohren EM, et al. DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination. Clin Nucl Med. 2022. PMID: 34269723. doi:10.1097/RLU.0000000000003847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。